Glaxosmithkline Pharmaceuticals Ltd. Fundamental & Technical Research, Share Price Today

NSE : GLAXO
NIFTY : Nifty 500
NIFTY SECTOR : Nifty MidSmall Healthcare

About Company

Glaxosmithkline Pharmaceuticals Limited is engaged in research, manufacture and make available a broad range of medicines and vaccines that benefit people. The company’s Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in anti-infectives and dermatology. Its R&D approach focuses on science related to the immune system, use of genetics and advanced technologies. Meanwhile, Its Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. The company is the leaders in India in the private segment.

Market Cap. ₹43,610 Cr.

52 Week - High/Low ₹3,088/1,842

P/E Ratio 51.30

P/B Ratio 24.44

Enterprise Value ₹42,656 Cr.

ROE % 32.96

RSI Value 43.11

EMA 50 2578.18

EMA 200 2430.2

Net Profit 585 Cr.

Net Profit 3year growth 63.52 Cr.

Net Profit 3 year (back) 358 Cr.

Debt to Equity 0.0 %

EPS Growth TTM 65.07 %

Current Ratio 1.83 %

100 Day SMA 2,377 Rs.

200 Day SMA 2,547 Rs.

21 Day SMA 2,772 Rs.

50 Day SMA 2,472 Rs.

Book Value 105 Rs.

EV/EBITDA Ratio 35

QoQ EPS Growth -8 %

QoQ Operating Profit Growth -10 %

QoQ Sales Growth -5 %

Sales Latest Quarter 946 Cr.

YoY Sales Growth 18 %

Market Cap. ₹43,610 Cr.

52 Week - High/Low ₹3,088/1,842

P/E Ratio 50.76

P/B Ratio 24.53

Enterprise Value ₹42,655 Cr.

ROE % 33.43

RSI Value 43.11

EMA 50 2578.18

EMA 200 2430.2

Net Profit 590 Cr.

Net Profit 3year growth 13.35 Cr.

Net Profit 3 year (back) 358 Cr.

Debt to Equity 0.0 %

EPS Growth TTM 62.41 %

Current Ratio 1.84 %

100 Day SMA 2,377 Rs.

200 Day SMA 2,547 Rs.

21 Day SMA 2,772 Rs.

50 Day SMA 2,472 Rs.

Book Value 105 Rs.

EV/EBITDA Ratio 34

QoQ EPS Growth -9 %

QoQ Operating Profit Growth -11 %

QoQ Sales Growth -6 %

Sales Latest Quarter 949 Cr.

YoY Sales Growth 18 %

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages